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Recently, we have reported the isolation of cDNA encoding a second human calcitonin gene-related peptide 
(hCGRP-II) [(1985) FEBS Lett. 183, 403407j. In this report we describe the isolation and characterization 
of the gene encoding hCGRP-II. This gene, designated CALC-II, is structurally closely related to the known 
CALC-I gene encoding human calcitonin (hCT) and hCGRP-I. In constrast to CALC-I, CALC-II does 
not seem to be alternatively expressed. The formation of a second, hCT-like mRNA by differential splicing 
of CALC-II transcripts is unlikely in view of the structure of CALC-II, and could not be demonstrated 
in tissues known to express CALC-I and CALC-II. 
Calcitonin CGRP Gene family 
1. INTRODUCTION 
The rat calcitonin (CT) gene is one of the first 
mammalian genes which have been shown to 
generate two mRNAs encoding different biologi- 
cally active peptides as a consequence of alter- 
native RNA processing events. The products of 
these mRNAs are the precursor to the calcium- 
regulating hormone calcitonin in the thyroidal C- 
cell, and the precursor to the calcitonin gene- 
related peptide (CGRP) in nervous tissues [l]. 
Analysis of the structure of the human calci- 
tonin (hCT) gene by our own and other laborato- 
ries has demonstrated that the same mechanism of 
alternative RNA processing leads to the synthesis 
of hCTmRNA (exons l-4) and hCGRPmRNA (ex- 
ons l-3,5 and 6) [2-61. During these studies we 
isolated, from a cDNA library of human medul- 
lary thyroid carcinoma (MTC) mRNA, a clone 
which was clearly derived from transcription of a 
second hCT/CGRP gene [7]. Nucleotide sequence 
analysis of this cDNA clone revealed that it con- 
tained regions with greater than 90% homology to 
part of exon 3 and the entire exon 5, and about 
Alternative splicing (Human) 
65% homology to exon 6 of the first hCT/CGRP 
gene. The cDNA sequence predicted the existence 
of a second hCGRP (hCGRP-II), differing from 
the known hCGRP (hCGRP-I) in 3 of its 37 amino 
acids. 
Southern-blot analysis of total human DNA 
hybridized to exon 3 and exon 5 sequences of the 
first hCT/CGRP gene as probes confirmed the ex- 
istence of the second gene [7]. The second hCT/ 
hCGRP gene has been shown to be a single copy 
gene located on chromosome 11, the same chromo- 
some that carries CALC-I [8,9]. 
In accordance with the report of the committee 
on the genetic constitution of human 
chromosomes 10, 11, and 12 [lo], the first and se- 
cond hCT/ CGRP genes are in the following refer- 
red to as CALC-I and CALC-II. 
This report presents the structure of CALC-II 
and compares it to the structure of CALC-I. The 
complete structure of the hCGRP-II precursor 
polypeptide molecule is predicted from the nucleo- 
tide sequencing results. The possibility of a second 
mature mRNA generated from CALC-II is assess- 
ed, both theoretically on the basis of the gene 
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structure, and empirically by screening of a variety 
of tissues for the presence of this RNA by Nor- 
thern blot analysis. 
2. MATERIALS AND METHODS 
2.1. Cosmid libraries 
Using the pJB8 cosmid vector cloning system, 
representative human gene libraries were con- 
structed with high molecular mass DNA from 
human medullary thyroid carcinoma (MTC) and 
human acute lymphatic leukaemia cells (ALL) 
after partial digestion with Sau3A [l 11. Following 
in vitro packaging, transduction to E. coli 1046 
and selection on ampicillin containing medium, 
approx. 100000 colonies were assayed for CALC- 
II sequences. 
2.2. Subcloning 
Subclones of cosmid fragments in pBR322 and 
Ml3 vectors, after digestion with the appropriate 
restriction enzymes, were obtained by ligation us- 
ing Tq ligase. E. coli K12 1592 cells were trans- 
formed with the resulting chimaeric plasmids. 
Transformants were grown on nitrocellulose fil- 
ters. Replica filters were screened-by hybridization 
to sequence specific DNA probes. 
2.3. DNA probes 
Total plasmid or ds Ml3 DNA containing spe- 
cific inserts, or isolated restriction enzyme 
fragments, were labeled by nick-translation to a 
specific activity of l-5 x 10’ dpm/pg and used as 
hybridization probes after heat denaturation. Syn- 
thetic oligonucleotides, with free 3 ‘- and 5 ’ -ter- 
minal hydroxyl groups [12] were radiolabeled to 
the same specific activity with [,-32P]ATP and Tq 
polynucleotide kinase. 
2.4. Nucleotide sequence analysis 
ds DNA restriction enzyme fragments were 
labeled 3 ‘- or 5 ‘-terminally using [,-32P]ddATP 
and terminal deoxynucleotidyl transferase, or 
[,-32P]ATP and T4 polynucleotide kinase, respec- 
tively. After a second restriction enzyme digestion 
and electrophoretic separation, sequences of frag- 
ments labeled at only one of their 3 ’ - or 5 ’ -termini 
were analyzed using the chemical modification 
technique [131. Fragments ubcloned into M 13 vec- 
tors (mp8, mp9, mpl0, and mpll) were analyzed 
using the dideoxy method [14]. 
2.5. Northern blots 
Total cellular RNA was isolated from cultured 
cells and tissues by the guanidine thiocyanate pro- 
cedure [15]. Poly(A)-rich RNA was prepared by 
oligo(dT)-cellulose chromatography. RNA sam- 
ples were treated with glyoxal and DMSO, size 
fractionated on agarose slabgel and transferred to 
Gene-Screen membranes (New England Nuclear, 
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Fig. 1. Schematic representation f CALC-II. The exons are indicated by the black boxes, the region corresponding to
exon 4 of CALC-I by the hatched box. Restriction enzyme fragments contained in subclones used for further structural 
analysis are indicated at the top. Other restriction enzyme recognition sites relevant to sequence analysis experiments 
are indicated on the line below the exons (B, BarnHI; Bg, BglII; H, HincII; Hd, HindIII; P, PstI; Pv, PvuII; S, SucI; 
Sm, SmaI; T, TuqI). Sequences derived by the chemical modification (C.M.) or Ml3 (M) dideoxy sequencing techniques 
are indicated by arrows. 
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EXON 2 
1 10 
met gly phe gin lys phe se= pro phe leu ala leu se= ile leu val 
CALC-I 5' . . . . ..ggtttatctcattcttcccttgcag AGAGGTGTC ATG GGC TTC CAA AAG TTC TCC CCC TTC CTG GCT CTC AGC ATC TTG GTC 
CALC-II 5' . . . . ..tagt~a~tcat~cttcc~tt&cag fGAGGcG$ ATG GGT TTC Cg AAG TTC TCC CCC TTC CTG GCT CTC AGT ATC TTG GTC 
==g 50 
20 
leu leu gln ala gly 8e= leu his ala ala pro phe a= 
CTG TTG CAG GCA GGC AGC CTC CAT GCA GCA CCA TTC AG gtaagacagcctgaagccagaacca . . . . ..cactgagtttgcttcccctccacag 
CTG TE CAG GCC GGC AGC CTC CA5 GCC GCC CCA TTC AG gtgagacagcctggagccaga&&c& . . . . ..c~ggagtttgcttccc~tccacag 
tY= gin 
40 
ala leu glu se= se= pro ala asp pro ala thr leu se= glu asp glu ala 
GCC CTG GAG AGC AGC CCA GCA GAC CCG CCC ACG CTC AGT GAG GAC GAA GCG 
FCC CTG GAG AGC AGC CCA --- GAC CCG GCC ACA CTC AGT AAA GAG GAC GCG - 
100 iy; glU asp 
60 70 
gln met lys ala se= glu leu glu gln glu gln glu arg glu gly se= a= 
CAG ATG AAG GCC AGT GAG CTG GAG CAG GAG CAA GAG AGA GAG GGC TCC AG 
CAG ATG AAG GCC AFT GAG CTG AAG CAG GAG CA5 GAG ACA CAG GGC TCC AG 
200 iys thr gln se 
EXON 5 
80 CGRP 90 
g ile ile ala gin lys arg ala cys asp thr ala thr cys val 
gcaaatcag A ATC ATT GCC CAG AAG AGA GCC TGT GAC ACT GCC ACC TGT GTG 
gcaaatcag C TCC ET GCC CAG &%G AGA GCC TGC AAC ACT GCC ACC TGT GTG -- -- 
= se= ala 250 asll 
110 
EXON 3 
30 
g se= 
G TCT 
G TCT 
50 
arg leu leu leu ala ala leu val gln asp tyr val 
CGC CTC CTG CTG GCT GCA CTG GTG CAG GAC TAT GTG 
CGC CTC CTG CTG GCT GCA CTG GTG CAG GAC TAT GTG. 
150 
gtgaggctccccaagcgctcagcac......cttctttctccatcc t 
gtgagg~tccccaagcgc~cagcac......cttctttctc~atc~ t 
100 
thr his arg leu ala gly leu leu se= arg se= gly 
ACT CAT CGG CTG GCA GGC TTG CTG AGC AGA TCA GGG 
ACT CAT CGG CTG GCA GGC TTF CTG AGC AGA TCA GGG 
300 
120 
gly val val lys asn asn phe val pro thr asn val gly se= lys ala phe gly arg arg arg arg asp leu gln ala term 
GGT GTG GTG AAG AAC AAC TTT GTG CCC ACC AAT GTG GGT TCC AM GCC TTT GGC AGG CGC CGC AGG GAC CTT CAA GCC TGA 
GGC ATG GTG AAG ACC AAC TTC GTG CCC ACC AAT GTG GGT TCC AAA GCC TTT GGC AGG CGC CGC AGG GAC CTT CAA GCC TGA 
-met se= 350 
400 EXON 6 
GCAGCTGAATGACTC----AAGAAG gtgactgcccttgtatgatgggatg . . . . . . . . . . ..ctgttattttcctcctccat---gg GTCACAATAAAGCTGAACT 
GCAGATGAATGACTCCAGGAAGAAG gt=actaccctaatgctatgggata............. ctcttcttttttcccctaatctcag GTTATCATGAAACTGAACT --- ---- 
450 500 
CA------CTTTTAATGTGTAATGAAAGCAATTTGTAGGACTT-CTTTGT---TT 
CACCATTTCTATTAATTTCTGTTGGTAAGAACTTGGTGAG~TGCCCCGT~MGA~A~ACATGTTT~ATCCT-M-GATACTG~GGGCACCTTTGTCACTT -- -_---- ----- -- -- 
550 600 650 
GAAAGGAACTATTGCTAAATGCAGAACAAGCTCATTGCAGTTACCTATTGTGCATC-TTTTT~TACTTGATTATGT~CCAT~TCTGACAGCATGTCTCATTGG 
GAAAGGAA-TGAAACTGAATGCAAAATAAGCTAATTCCA--TATTTGCTGTGCATC~TT~TATATTT~TTCTATGTCCAGT~GTG-ATGGCATCTCTCATTGA ___ -- --_-- -- - -- - - 
700 750 
CTTATCTGGTAGCAAATCTAGGCCCCGTCAGCCACCCTATTGA-CATTGGTGGCTCTGCT~CCTCAGGGGGACATG~TCACTGCCTCTTG-GGCATCTGGGGAC 
CTTATCTGGTAGCAAACTGGTTCTTTCGGAGCCATCCTGTTGATCAT--GCAGCTCCACC~CCTTAGGGGGACGTG~TCACTGCCTGTTGTGGTCTCCGAGGAC -- -- --- -- - ----- 
800 850 
ACATGGTA------ATGCTGTGCCTTGAC-----AGMGT----------ATTTGTTT~G~TGTC~T~TGT--CATTTGTG~CTCTATC~TT~T 
ACATGGTAATGGTGATGCTGTGCCTTGTTATCTAAGAACAC - - 
900 950 
GTATTTTCTATACCCTT tcaatggaatctctgctgctattta--- 
ATATTTTGGGTAC~TT-GTTTCAAAACCTTGGTGATGCATTAC~CTTGTTTTCTTATGT~T~T~TGATGATGATGATGAT~T~T~TATTTTTGAGTGCT - - -- 
TACTatgtatgggccagatattattttga------ 
Fig.2. Comparison of the nucleotide sequences of exons 2, 3,5 and 6 of CALC-I with the equivalent regions of CALC- 
II. Gaps were introduced to maximize homologies. Base substitutions in CALC-II are underlined. The amino acid se- 
quence of the hCGRP-I precursor is indicated; substitutions in the hCGRP-II precursor are indicated underneath. 
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Boston, USA). The membranes were pre-hybrid- present within this clone. Cos2CALC-II, contain- 
ized, hybridized to radiolabeled probe and washed ing the entire CALC-II gene, was isolated from the 
as prescribed by the manufacturer. When oligo- library constructed with DNA from acute lym- 
nucleotides were used as hybridization probes, the phatic leukaemia cells. The 2.6 kb Tag1 fragment 
hybridization temperature was lowered from 42 to was subcloned from CoslCALC-II. 2.3 kb and 1 .l 
32”C, and the washing procedure was carried out kb TaqI fragments and a 1.3 kb PstI fragment 
at 30 rather than 65°C. were subcloned from cos2CALC-II (fig. 1). 
3. RESULTS 
The insert of cDNA clone pCGRP-4 [7] was 
used as probe in the screening of cosmid libraries 
of human DNA for CALC-II specific clones. The 
3 ’ -terminal SacI-PstI part of this insert, contain- 
ing sequences partially homologous to exons 5 and 
6 of CALC-I, should detect a 2.6 kb TaqI frag- 
ment within CALC-II; the 5 ‘-terminal PstI-Sac1 
part, containing sequences partially homologous 
to exon 3 of CALC-I, should detect a 2.3 kb Z’uqI 
fragment derived from CALC-II [7]. CoslCALC- 
II, isolated from the cosmid library of human 
DNA from MTC tissue, was shown to contain the 
2.6 kb Tag1 fragment, but not the 2.3 kb TaqI 
fragment, indicating that only part of CALC-II is 
Nucleotide sequences within these subcloned 
fragments were analyzed using the chemical modi- 
fication technique, and by dideoxy sequencing 
after further subcloning into Ml3 vectors (fig.1). 
These analyses revealed the presence within 
CALC-II of regions with about 90% homology to 
exons 2, 3 and 5 of CALC-I. The sequence of the 
non-coding exon 6 of CALC-I is 65% homologous 
to the corresponding region of CALC-II. From 
these sequences, the structure of the complete 
precursor polypeptide for hCGRP-II can be pre- 
dicted (fig.2). 
Between exons 3 and 5 of CALC-II, a region 
with about 50% homology to exon 4 of CALC-I 
(the hCT encoding exon) is present (fig.3). The 1.1 
kb TaqI fragment encompassing this region was 
used as probe in the screening of human tissues for 
EXON 4 
leu asp se= pro srg 
CALC-I 5'-----ttccc-tgcsg C CTG GA-C AGC CCC AGA 
CALC-II 5'-----ttcccttgcsg C -TA GAGC AGT CCT AGA 
se= lys srg 
cslcitonin 
cys gly ssn leu se= thr cys 
TCT AAG CCC -- TGC GGT AAT CTG AGT ACT TGC 
TTT AAG TAG CA TAT AGT AAT CTG AGT ACC TGC 
tyr ser 
met leu gly thr tyr thr gln asp phe ssn 1YS phe his thr phe pro gln thr ala ile gly vsl 
ATG CTG GGC ACA TAC ACG CAG GAC TTC AAC AAG TTT CAC ACG TTC CCC CAA ACT GCA ATT GGG GTT 
TTG CAG GGC ACA TAC TTG CAG TAC CTG AAA AAC TTT CAT ATG TTC CCT GGC ATC AAC TTC GGG CCT 
leu gin leu tyr leu lys as* met gly ile asn phe Pro 
gly ala pro gly lys lys srg asp met se= se= asp leu glu srg asp his srg pro his vsl se= 
GGA GCA CCT GGA AAG AAA AGG GAT ATG TCC AGC GAC TTG GAG AGA GAC CAT CGC CCT CAT GTT AGC 
GAA ATT CCT GGC AAG AAT AGG GAC ATA GTC AAC AGC TTG CAG AGG GAC CAC TAC CCG ACT CCA TGG 
glu ile am ile vsl as" se= gin ty= thr pro t=p 
met pro gln 8811 ala 8811 stop stop 
ATG CCC CAG AAT GCC AAC TAA ACT CCT CCC TTT CCT TCC TAA TTTCCCTTCTTGCATCC--TTCCTATAACTTGATGCAT 
TCC CCC GGG TGG CAG CTG AAC TTC TCT CAA CTC TCC --- TGA TTCCCCTTCTTGC-TCCACTT-TATGAACCTGATGCAT 
se= gly trp gin leu ssn phe se= gin leu se= stop 
GTGGTTTGGTTCCTCTCTGGTGGCTCTTTGGGCTGGTATTGGTGGCTTTCCTTGTGGCAGAGGATGTCTC~CTTCAGATGGGAGG~GAGAGCAGGACTCACAGG 
GTGGATT----CCTCTCTGATTTGTCTTCATGCTGGTATTGGTATTTTTGCTTATGACAGAG~TGTTTTGMGACCTCAGGATGG~GGGMGACAG------CAGG 
CATTTGA-GGAATAAAATTATTTTTCCCCAAAGA tctgsgctgtggtgg-tcattgctct............ 
ACTACGATAAAATAAGCACGTCCTT----AATGC cttggcgttsgstgsstcsst-ctst............ 
Fig.3. Nucleotide sequence of the exon 4-like region in CALC-II compared to exon 4 of CALC-I. Gaps were introduced 
to maximize homology. The amino acids encoded by the CALC-I sequence are indicated; hCT is underlined. The amino 
acids which theoretically might be encoded by this part of CALC-II and which differ from those encoded by CALC-I 
are indicated underneath. 
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alternative expression of CALC-II, as has been 
established for CALC-I. Total cellular RNA (50 
fig) and poly(A)-rich RNA (20-50 pg) from human 
MTCs (sporadic and familial), pituitary, hypo- 
thalamus, thyroid, phaeochromocytoma nd lung 
tumours of various types was electrophoresed, 
Northern-blotted and hybridized to this probe. In 
none of these tissues could mRNA containing se- 
quences derived from the exon 4-like region of 
CALC-II be demonstrated. 
A region of 111 nucleotides with about 50% 
homology to the sequence directly preceding exon 
1 and part of exon 1 of CALC-I is located within 
the 1.3 kb PstI fragment of CALC-II (fig.1) at ap- 
proximately the same position as is exon 1 in 
CALC-I. This region is presented in fig.4. Subse- 
quently, it has been shown that transcripts of this 
region of CALC-II are present in hCGRP-II 
mRNA, which was isolated from Ewing sarcoma 
cells. These cells have been shown to express 
CALC- II, but not CALC-I, using probes specific 
for either one of these genes (manuscript in prepa- 
ration). The 20-mer synthetic oligonucleotide 
5 ’ -GATGCTGAGAGCCAGGAAGG-3 ’ , com- 
plementary to part of exon 2 of CALC-I, and, with 
one mismatch, to nucleotides 33 to 52 of exon 2 of 
CALC-II (fig.2) was labeled 5 ’ -terminally, hybrid- 
ized to poly(A)-rich RNA from Ewing sarcoma 
cells and extended using reverse transcriptase. The 
nucleotide sequence of the products revealed that 
exon 2 of CALC-II is linked to the sequence in 
fig.4 as indicated, and allowed unambiguous con- 
firmation of the sequence up to position 70 in 
fig.4. 
Fig.4. Comparison of nucleotide sequences of exon 1 of 
CALC-I and a region at the equivalent position in 
CALC-II. Gaps have been introduced to maximize 
homology. Identical nucleotides in both sequences are 
underlined. 
4. DISCUSSION 
We have previously reported the nucleotide se- 
quence of cDNA corresponding to hCGRP-II 
mRNA isolated from human MTC [7], hCGRP-II 
has since been proven to have cardiovascular ac- 
tivity comparable in its effects and potency to 
hCGRP-I (I. Marshall et al., in preparation; A. 
France-Cereceda et al., in preparation). 
In the present report we show that CALC-II has 
a striking resemblance in overall structure to the 
known CALC-I gene. From the sequence of exons 
2, 3 and 5 of CALC-II the structure of the precur- 
sor polypeptide for hCGRP-II can be predicted 
(fig.2). The sequence contains an open reading 
frame of 381 nucleotides, coding for a precursor 
protein of 127 amino acids. The first 237 nucleo- 
tides specify the 79 amino acid NHz-terminal pep- 
tide. Comparison to the equivalent region in 
hCGRP-I mRNA reveals 27 base substitutions, in- 
sertions, or deletions, altering 13 of the 
NHz-terminal amino acids. The next 120 nucleo- 
tides encode hCGRP-II, and a COOH-terminal 
tetrapeptide. Within this region only 6 base sub- 
stitutions occur, causing 3 of the 37 amino acids of 
hCGRP-II to differ from hCGRP-I. 
The nucleotide sequence further predicts that 
hCGRP-II, like hCGRP-I, is excised from its pro- 
tein precursor by proteolytic cleavage at pairs of 
basic amino acids flanking hCGRP-II and that 
hCGRP-II is COOH-terminally amidated. The 
COOH-terminal tetrapeptide resulting from cleav- 
age of the hCGRP-II precursor is identical to that 
of the hCGRP-I precursor. 
The nucleotide sequences of the cDNA clone [7] 
and the genomic clone differ at four points. One of 
these differences (G is A in cDNA) is located 
within the coding region of the NHz-terminal pep- 
tide, at nucleotide 229 in fig.2. As a consequence, 
the Sac1 recognition site (5 ’ -GAGCTC-3 ’ ) present 
in the cDNA clone is absent in the genomic clone, 
and the serine residue predicted by the cDNA is 
changed to a glycine residue by the genomic se- 
quence. The remaining three differences are 
located within the non-coding exon 6 (see below). 
It has been suggested that CT and CGRP exons 
derive from a common primordial gene, and that 
the CT/CGRP gene arose by duplication and se- 
quence divergence vents [6]. The present data in- 
dicate that biological diversity was increased 
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further by gene duplication, resulting in CALC-I 
and CALC-II. Since also in rat a second CGRP has 
been found [16], it is probable that gene duplica- 
tion occurred prior to the rodent-primate split 70 
million years ago. Fig.5 compares the amino acid 
sequences of the precursor polypeptides of CGRPs 
in rat and human. Identical amino acids are found 
at 78 positions in all four precursors; of these 78 
positions, 43 are located within the 49 COOH- 
terminal residues, which constitute the CGRPs and 
the COOH-terminal peptides. The number of dif- 
ferences between the human NHz-terminal pep- 
tides (13 out of 80 amino acids) is strikingly lower 
than that between the rat NH2-terminal peptides 
(41 out of 88 amino acids). This might reflect a dif- 
ference in biological function of the NHz-terminal 
peptides in rat and human. The two additional 
potential cleavage sites (Arg-Lys) in the rat ,f3- 
CGRP precursor [16] are absent from the hCGRP- 
II precursor. 
In hCGRP-I mRNA, transcripts of two non- 
coding exons, exons 1 and 6, are contained. Within 
CALC-II, a region 65% homologous to exon 6 of 
CALC-I is present. As shown by the cDNA data 
[7], exon 6 of CALC-II is at least 551 nucleotides 
long, as opposed to 431 nucleotides in CALC-I. 
The AATAAA sequence (nucleotides 957-962 in 
Fig.5. Amino acid sequences of the precursor polyepep- 
tides of the human and rat CGRPs. Amino acids differ- 
ing from the consensus residue at that point are 
underlined. Gaps are included in order to obtain max- 
imal homology. 
fig.2) is most likely to function as poly(A)-addition 
enzyme recognition signal, and polyadenylation 
probably takes place at the T-residue at position 
980. 
Three differences in the nucleotide sequence of 
exon 6 were observed between the CALC-II gene 
and the cDNA sequence reported earlier [7]. These 
differences are located at nucleotides 450 (T is C in 
cDNA), 489 (G is C in cDNA, resulting in the 
presence of a BstNI site in the cDNA at this point), 
and 698 (G is A in cDNA) (fig.2). These dif- 
ferences may be the result of reverse-transcription 
errors and/or naturally occurring nucleotide se- 
quence polymorphisms. 
The sequence presented in fig.4 shows the 
highest degree of homology to exon 1 of CALC-I 
within the region examined. Its position and the 
fact that the putative RNA polymerase recognition 
signal in CALC-I (nucleotides 12-22 in fig.4) is 
well conserved in CALC-II make it likely that this 
region functions as exon 1 in CALC-II. 
In view of the fact that CALC-II has so many 
features in common with CALC-I, the question 
arises whether transcripts of CALC-II may be pro- 
cessed in such a way that an mRNA equivalent o 
hCT mRNA is formed. Examination of the exon 
4-like region of CALC-II (fig.3) makes this unlike- 
ly. Splicing at the site equivalent o the exon 3-exon 
4 junction in hCT mRNA would result in stop- 
codons within the reading frame of the precursor 
polypeptide. Furthermore, the cysteine residue at 
position 1 of all CTs studied so far is not encoded 
by this sequence, and the amino-terminal Lys-Arg 
excision signal is lacking. 
In conclusion, CALC-II seems to be a pseudo- 
gene for hCT, but a structural gene for hCGRP. 
Since antibodies raised to hCGRP-I are bound to 
cross-react with hCGRP-II, it is unclear whether 
hCGRP-I or -11 has been detected by immuno- 
chemical methods in human tissues. The presence 
of immunoreactive hCGRP may be the result of 
expression of CALC-II and not of alternate ex- 
pression of CALC-I. A genomic clone, AhCa12, 
containing a second human calcitonin gene has 
also been isolated by Jonas et al. [6]. Restriction 
analysis and partial sequence analysis was stated to 
indicate that ‘hhCal2 contains regions with 
homology to the common region, calcitonin and 
CGRP exons, but that this gene encodes neither 
the calcitonin nor CGRP mRNA’ (i.e. hCGRP-I 
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mRNA). Since according to our data, the human 
genome does not contain regions hybridizing to 
CGRP specific probes other than those in CALC-I 
and CALC-II, it seems probable that AhCal con- 
tains CALC-II. If so, hybridization under 
stringent conditions of a calcitonin-specific rat 
cDNA probe to hhCALC2 [6] remains to be ex- 
plained, unless this probe also contained ‘common 
region’ derived sequences. 
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